XTalks
NOVEMBER 6, 2020
The Burnaby, BC-based company developed the oral DNA-based vaccine using its proprietary bacTRL Gene Therapy Platform, which uses genetically modified bifidobacteria as carriers of genetic vaccine elements on a DNA plasmid. Related: Red Meat Allergy Test Gets FDA Clearance. “We
pharmaphorum
JANUARY 20, 2021
Once inhaled into the lungs, the virus sets about binding to and inserting its own DNA into the targeted bacteria. This interrupts replication patterns and, ultimately, kills the bacterium.”. Once inhaled into the lungs, the virus sets about binding to and inserting its own DNA into the targeted bacteria. I was really sick.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
NOVEMBER 17, 2022
It is believed that the term synthetic biology was created in 1970 by geneticist, Waclaw Szybalski 1 as work was being carried out on the development of DNA sequencing and synthesis techniques. These factors can significantly contribute to the growth of the synthetic biology market, it adds. . Brady and colleagues turned to algorithms.
XTalks
AUGUST 2, 2023
5) Lynparza (Olaparib) Lynparza is a PARP inhibitor , meaning it inhibits poly ADP ribose polymerase (PARP), an enzyme involved in DNA repair. It is a macrolide lactone that was discovered in the fermentation broth of a Japanese soil sample that contained the bacterium Streptomyces tsukubensis. Global sales of Prograf totalled 198.8
XTalks
DECEMBER 24, 2020
Charpentier demonstrated that the CRISPR/Cas system functions to provide adaptive immunity against foreign DNA in prokaryotes such as bacteria and archaea. The system can be used to precisely edit out portions of DNA flanked by CRISPR sequences. The system can be used to precisely edit out portions of DNA flanked by CRISPR sequences.
Expert insights. Personalized for you.
75 
Let's personalize your content